Subscribe to Updates

    Get the latest creative news from CRYPTO NOUNCE.

    What's Hot

    Between Arbitrum’s [ARB] surging demand and whirlwind drop-off

    April 1, 2023

    Solana’s NFT space can recover soon, but SOL’s troubles are far from over 

    April 1, 2023

    Terra’s branding at MLB opener draws attention from spectators

    April 1, 2023
    Facebook Twitter Instagram
    Facebook Twitter Instagram Vimeo
    Cryptonounce.com
    Contact
    • Business
      • Deals
      • investors
      • IPO
      • Startups
      • Wall Street
    • Markets
      • Bonds
      • Commodities & Futures
      • Currencies
      • Funds & ETFs
      • Stocks
    • Crypto
      • Alticoins News
      • Binance News
      • Bitcoins News
      • Blockchain News
      • Ethereum News
      • Token Sales News
      • XRP News
    • Technology
      • Artificial Intelligence
      • Big Data
      • Cloud Computing
      • Cybersecurity
      • Gaming
      • Internet of Things
      • Mobile
      • Social Media
      • Transportation
      • VR & AR
    • FinTech
    • Personal finance
    • Grides
      • Crypto
      • FinTech
      • Investing
      • Personal Finance Guides
      • Techonology
    • Tools
      • Coins
      • ICO List
      • Organigations
      • Events
    Cryptonounce.com
    Home » South African company creates copy of Moderna vaccine in breakthrough for low income nations
    Organigations

    South African company creates copy of Moderna vaccine in breakthrough for low income nations

    AdmincryptBy AdmincryptFebruary 4, 2022No Comments4 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    An effort led by the World Health Organization (WHO) to increase vaccine availability to middle and low income nations had its first breakthrough Thursday, when a South African biotechnology company revealed it created a near-copy of the Moderna Covid vaccine.

    Afrigen Biologics and Vaccines, based in Cape Town, South Africa, announced Thursday that it has made microliters of a Moderna vaccine-clone.

    The company is working on cloning the vaccine as a part of the WHO’s effort to make technology and treatments related to Covid more widely available around the world.

    Around 70 percent of the world’s mRNA vaccines – the Moderna and Pfizer-BioNTech shots – have been given to high incomes nations, leaving lower and middle income countries vulnerable to the virus.

    Only around 11 percent of Africans are vaccinated, according to Our World in Data, with some countries having vaccinated less than one-in-ten residents.

    Afrigen, a South African biotechnology company, believes that it has successfully recreated the Moderna Covid vaccine in a lab. It is the first step in a major effort to make the shots more available in low and middle income countries. Pictured: Afrigen scientists work in a company lab

    Afrigen, a South African biotechnology company, believes that it has successfully recreated the Moderna Covid vaccine in a lab. It is the first step in a major effort to make the shots more available in low and middle income countries. Pictured: Afrigen scientists work in a company lab

    Moderna has said that it will not enforce its patents on its vaccine during the pandemic, making the shot the prime candidate for this kind of replication (file photo)

    Moderna has said that it will not enforce its patents on its vaccine during the pandemic, making the shot the prime candidate for this kind of replication (file photo)

    ‘Moderna and Pfizer-BioNTech’s vaccines are mainly still going to just the richest countries… Our objective is to empower other countries to make their own,’ Martin Friede, the WHO official coordinating the effort, told Nature.

    This is just the first on many steps in the process of recreating and launching a new version of the Moderna shot that will be cheaper and more accessible for these countries.

    It will likely not be available for use in people until next year, but the researchers have now gotten over one of the first major humps.

    The vaccine was produced without help from Moderna, Pfizer or BioNTech. The WHO said it reached out the firms, but did not receive help.

    Africa has struggled to access the Covid vaccines,

    Africa has struggled to access the Covid vaccines, with only around 11% of the continent’s population fully vaccinated. The researchers hope the breakthrough discovery will be the first step to eventually making the shots widely available on the continent. Pictured: A child in Johannesburg, South Africa, receives a shot of a COVID-19 vaccine on October 21

    ‘We didn’t have help from the major COVID vaccine producers,’ Gerhardt Boukes, chief scientist at Afrigen, said. 

    ‘So we did it ourselves to show the world that it can be done, and be done here, on the African continent.’ 

    Moderna’s shot was chosen since the company said it would not enforce its patents during the pandemic and more information on it was available publicly.

    The effort began at the University of Witwaterstrand, in Johannesburg, South Africa. Using data published online by researchers at Stanford University, they developed a DNA molecule that could serve as a template to synthesize the mRNA needed to create the base of the vaccine.

    Afrigen then became the center of the WHO’s initiative, and upon starting the endeavor to recreate the shot. 

    Upon taking on the project, the company reports receiving offers of assistance from scientists around the world, including some at the National Institutes of Health (NIH) in the U.S.

    Now that Afrigen has cleared the first hurdle, the company hopes Moderna will assist them – or at least not get in their way – going forward.

    Moderna has not been as vocal as Pfizer on the issue of potential waiving or circumventing patents for the vaccines, but the company has staked a claim over the shots it develops and distributes.

    The company has got into a spat with the NIH over who invented the mRNA vaccines, with the agency claiming three of its scientists deserved to be names as co-inventors on the patent – though the firm disagreed.

    Stephane Bancel, CEO of Moderna, also said last year that an effort to have the federal government waive patent rights over the vaccines would do little to actually make the vaccines more widely available.

    The WHO and other experts who worked on the effort to clone the Moderna shot are now hoping the Moderna will license its vaccine to companies in many low and middle income nations so it can be cheaply produced generically without fear of the company taking legal action. 

    Nature reports that Moderna did not comment on the matter.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleEurope is heading for a Covid ‘ceasefire’ that could lead to the END of the pandemic, says WHO
    Next Article Covid symptoms appear just two days after being exposed to the virus, study shows
    Admincrypt
    • Website

    Related Posts

    World Health Organization says healthy kids and teens don’t need Covid vaccinations

    March 29, 2023

    Children addicted to video games are attacking their PARENTS, experts warn 

    March 28, 2023

    World Health Organization says risk of Marburg virus is ‘very high’ across parts of Africa

    March 27, 2023

    Experts call for lab leak-denying doctor Jeremy Farrar to be sacked from World Health Organization

    March 7, 2023

    Leave A Reply Cancel Reply

    Our Picks
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss
    XRP News

    Between Arbitrum’s [ARB] surging demand and whirlwind drop-off

    By AdmincryptApril 1, 20230

    Korean exchange Upbit could be the second-largest ARB holder per accumulation speculation ARB’s value has…

    Solana’s NFT space can recover soon, but SOL’s troubles are far from over 

    April 1, 2023

    Terra’s branding at MLB opener draws attention from spectators

    April 1, 2023

    Tron [TRX]: Will new upgrade foster stagnant staking activity? Gauging…

    April 1, 2023

    Subscribe to Updates

    Get the latest creative news from CRYPTO NOUNCE.

    NEWS
    • Business
    • Crypto
    • Blockchain
    • Markets
    • Technology
    FEATURED SECTIONS
    • Coins
    • ICO List
    • Organigations
    • Events
    • Grides
    FEATURED LINKS
    • Story of the day
    • Videos
    • Infographics
    CONNECT WITH US
    • Facebook
    • Twitter
    • Telegram
    • LinkedIn
    • Pinterest
    ABOUT US
    • Contact
    • Advertise
    • Sitemap
    Copyright © 2023 Cryptonounce All rights reserved. Cryptonounce.
    • Home
    • Buy Now

    Type above and press Enter to search. Press Esc to cancel.

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?